• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    DiaMedica Therapeutics Inc. - Common Stock (NQ:DMAC)

    6.880 +0.060 (+0.88%)
    Streaming Delayed Price Updated: 12:52 PM EDT, Jul 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 73,077
    Open 6.820
    Bid (Size) 6.820 (200)
    Ask (Size) 6.860 (200)
    Prev. Close 6.820
    Today's Range 6.540 - 6.930
    52wk Range 4.014 - 10.42
    Shares Outstanding 37,953,711
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    News headline image
    DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction
    From DiaMedica Therapeutics Inc.
    Via Business Wire

    Performance

    YTD
    -13.2%
    -13.2%
    1 Month
    +9.6%
    +9.6%
    3 Month
    +10.6%
    +10.6%
    6 Month
    -17.4%
    -17.4%
    1 Year
    +33.6%
    +33.6%

    More News

    Read More
    News headline image
    DiaMedica Receives FDA Feedback on DM199 Preeclampsia Nonclinical Program
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    News headline image
    DiaMedica (DMAC) Q4 2025 Earnings Transcript ↗
    Via The Motley Fool
    Topics Intellectual Property
    DiaMedica Therapeutics (NASDAQ:DMAC) Posts Wider Q1 Loss but Clinical Catalysts Fuel Stock Resilience ↗
    Via Chartmill
    News headline image
    DiaMedica Therapeutics to Present at the Jefferies Global Healthcare Conference 2026
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    News headline image
    DiaMedica Therapeutics Announces 75% Enrollment Milestone in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    News headline image
    DiaMedica Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    News headline image
    DiaMedica (DMAC) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    Topics Death
    News headline image
    Earnings Scheduled For November 12, 2025 ↗
    Via Benzinga
    News headline image
    DiaMedica Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    News headline image
    DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    News headline image
    RedChip's Biotech Virtual Investor Conference Replays Now Available
    Via ACCESS Newswire
    News headline image
    RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
    Via ACCESS Newswire
    News headline image
    DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    News headline image
    Top Wall Street Forecasters Revamp DiaMedica Therapeutics Expectations Ahead Of Q4 Earnings ↗
    Via Benzinga
    News headline image
    DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    News headline image
    DiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia
    From DiaMedica Therapeutics Inc
    Via Business Wire
    News headline image
    DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    News headline image
    DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    News headline image
    DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Via Benzinga
    News headline image
    DiaMedica Therapeutics Inc (NASDAQ:DMAC) Reports Q3 2025 Earnings and Clinical Progress ↗
    Via Chartmill
    News headline image
    DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
    From DiaMedica Therapeutics Inc.
    Via Business Wire
    News headline image
    An Overview of DiaMedica Therapeutics's Earnings ↗
    Via Benzinga

    Frequently Asked Questions

    Is DiaMedica Therapeutics Inc. - Common Stock publicly traded?
    Yes, DiaMedica Therapeutics Inc. - Common Stock is publicly traded.
    What exchange does DiaMedica Therapeutics Inc. - Common Stock trade on?
    DiaMedica Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for DiaMedica Therapeutics Inc. - Common Stock?
    The ticker symbol for DiaMedica Therapeutics Inc. - Common Stock is DMAC on the Nasdaq Stock Market
    What is the current price of DiaMedica Therapeutics Inc. - Common Stock?
    The current price of DiaMedica Therapeutics Inc. - Common Stock is 6.880
    When was DiaMedica Therapeutics Inc. - Common Stock last traded?
    The last trade of DiaMedica Therapeutics Inc. - Common Stock was at 07/24/26 12:52 PM ET
    What is the market capitalization of DiaMedica Therapeutics Inc. - Common Stock?
    The market capitalization of DiaMedica Therapeutics Inc. - Common Stock is 261.12M
    How many shares of DiaMedica Therapeutics Inc. - Common Stock are outstanding?
    DiaMedica Therapeutics Inc. - Common Stock has 261M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.